While CDK9 is crucial for tumorigenesis and CDK9 inhibition shows efficacy in the therapy of various cancers, including LUAD 15, 16, 17, we found that CDK9 is only marginally overexpressed in LUAD and its expression was not correlated with LUAD patient survival (see Figure S5E-I). This evidence concerns the gene CDK9 and cancer.